![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 28539 |
FusionGeneSummary for PPP6R3_GAL |
![]() |
Fusion gene information | Fusion gene name: PPP6R3_GAL | Fusion gene ID: 28539 | Hgene | Tgene | Gene symbol | PPP6R3 | GAL | Gene ID | 55291 | 51083 |
Gene name | protein phosphatase 6 regulatory subunit 3 | galanin and GMAP prepropeptide | |
Synonyms | C11orf23|PP6R3|SAP190|SAPL|SAPLa|SAPS3 | ETL8|GAL-GMAP|GALN|GLNN|GMAP | |
Cytomap | 11q13.2 | 11q13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | serine/threonine-protein phosphatase 6 regulatory subunit 3SAPS domain family, member 3sporulation-induced transcript 4-associated protein SAPL | galanin peptidesgalanin prepropeptidegalanin-message-associated peptidegalanin-related peptidegalanin/GMAP prepropeptide | |
Modification date | 20180520 | 20180523 | |
UniProtAcc | Q5H9R7 | P22466 | |
Ensembl transtripts involved in fusion gene | ENST00000393799, ENST00000530427, ENST00000393800, ENST00000534534, ENST00000524845, ENST00000265637, ENST00000524904, ENST00000393801, ENST00000265636, ENST00000529710, ENST00000527403, | ENST00000538401, ENST00000265643, | |
Fusion gene scores | * DoF score | 18 X 11 X 10=1980 | 4 X 3 X 4=48 |
# samples | 28 | 4 | |
** MAII score | log2(28/1980*10)=-2.82200169802201 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: PPP6R3 [Title/Abstract] AND GAL [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PPP6R3 | GO:0043666 | regulation of phosphoprotein phosphatase activity | 16716191 |
Tgene | GAL | GO:0010737 | protein kinase A signaling | 17982695 |
Tgene | GAL | GO:0019933 | cAMP-mediated signaling | 17982695 |
Tgene | GAL | GO:0045944 | positive regulation of transcription by RNA polymerase II | 24517231 |
Tgene | GAL | GO:0051464 | positive regulation of cortisol secretion | 17982695 |
Tgene | GAL | GO:0051795 | positive regulation of timing of catagen | 22329353 |
Tgene | GAL | GO:1902608 | positive regulation of large conductance calcium-activated potassium channel activity | 24602615 |
Tgene | GAL | GO:1902891 | negative regulation of root hair elongation | 22329353 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | UCS | TCGA-N5-A59E-01A | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000393799 | ENST00000538401 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000393799 | ENST00000265643 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
intron-intron | ENST00000530427 | ENST00000538401 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
intron-intron | ENST00000530427 | ENST00000265643 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000393800 | ENST00000538401 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000393800 | ENST00000265643 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000534534 | ENST00000538401 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000534534 | ENST00000265643 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000524845 | ENST00000538401 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000524845 | ENST00000265643 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000265637 | ENST00000538401 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000265637 | ENST00000265643 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000524904 | ENST00000538401 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000524904 | ENST00000265643 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000393801 | ENST00000538401 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000393801 | ENST00000265643 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000265636 | ENST00000538401 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000265636 | ENST00000265643 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000529710 | ENST00000538401 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000529710 | ENST00000265643 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000527403 | ENST00000538401 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
5CDS-intron | ENST00000527403 | ENST00000265643 | PPP6R3 | chr11 | 68338572 | + | GAL | chr11 | 68458385 | + |
Top |
FusionProtFeatures for PPP6R3_GAL |
![]() |
Hgene | Tgene |
PPP6R3 | GAL |
Endocrine hormone of the central and peripheral nervoussystems that binds and activates the G protein-coupled receptorsGALR1, GALR2, and GALR3. This small neuropeptide may regulatediverse physiologic functions including contraction of smoothmuscle of the gastrointestinal and genitourinary tract, growthhormone and insulin release and adrenal secretion.{ECO:0000269|PubMed:1370155, ECO:0000269|PubMed:1722333,ECO:0000269|PubMed:25691535}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PPP6R3_GAL |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PPP6R3_GAL |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
PPP6R3 | KDM6A, TNFAIP3, USP21, USP36, USP49, PPP6C, PRKDC, HDAC1, HDAC2, ELAVL1, SIRT7, TERF2IP, TINF2, TFAP4, GRK5, PFAS, BRCA1, ECT2, NOTCH1, LATS1, GPSM1, HDAC11, USP10, ANKRD28, MOB1A, MOB1B, ACAD11, ANKRD44, ANKRD52, AP1B1, AP2A1, AP2A2, AURKA, DNAJC11, ECH1, ERLIN2, PPP6R1, PPP6R2, CDC37, ENAH, ETFA, HSP90AA1, HSP90AB1, RUVBL2, SRRT, TPM1, USP7, CSNK1E, SNAI2, RNF2, GPHA2, RPS6KB2, UNK, DIEXF, NSUN5, EIF4A3, TIPRL, NTRK1, CEP44, CEP19, XPO1, ZNRF2, ZNF746, TRMT2A, TRIM25, TES | GAL | ELAVL1, SGTA, HLA-DPA1, CEACAM21, MGAT4C, MMP10, FCGRT |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PPP6R3_GAL |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for PPP6R3_GAL |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | GAL | C0011570 | Mental Depression | 5 | PSYGENET |
Tgene | GAL | C0011581 | Depressive disorder | 5 | PSYGENET |
Tgene | GAL | C0525045 | Mood Disorders | 5 | PSYGENET |
Tgene | GAL | C0085762 | Alcohol abuse | 4 | PSYGENET |
Tgene | GAL | C0001973 | Alcoholic Intoxication, Chronic | 2 | PSYGENET |
Tgene | GAL | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Tgene | GAL | C0020429 | Hyperalgesia | 1 | CTD_human |
Tgene | GAL | C0020538 | Hypertensive disease | 1 | CTD_human |
Tgene | GAL | C0021368 | Inflammation | 1 | CTD_human |
Tgene | GAL | C0024809 | Marijuana Abuse | 1 | PSYGENET |
Tgene | GAL | C0027796 | Neuralgia | 1 | CTD_human |
Tgene | GAL | C0039231 | Tachycardia | 1 | CTD_human |
Tgene | GAL | C0338715 | Drug-induced depressive state | 1 | PSYGENET |
Tgene | GAL | C4225318 | EPILEPSY, FAMILIAL TEMPORAL LOBE, 8 | 1 | UNIPROT |